Clinical Trial Update: A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC

View source ↗

Summary

This is a prospective study to validate blood-based biomarkers associated with differences in the efficacy of neoadjuvant therapy for non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Tang-Du Hospital | Conditions: Non-small Cell Lung Cancer | Status: NOT_YET_RECRUITING